The BiosearchTech Blog

When you don’t need an EUA for SARS-CoV-2 testing

On March 25, 2020, the US Food and Drug Administration (FDA) held the first of a series of virtual town halls they will be holding to answer technical questions about developing, validating, and implementing…

The BiosearchTech Blog

Building resilience into SARS-CoV-2 testing workflows: considerations for choosing an RNA isolation method

Posted on Wed, Oct 21, 2020 @ 09:00 AM

As we start to close in on a full year of the COVID-19 pandemic, molecular diagnostics labs are still facing supply ...

Topics: Molecular Diagnostics, Genomics, Coronavirus

Pressing COVID-19 testing issues of today and the near future

Posted on Wed, Aug 26, 2020 @ 07:57 AM

Following up with the panelists from our recent COVID-19 webinar, Part 3 of 3 In the previous two blog posts in this ...

Topics: Molecular Diagnostics, Genomics, Coronavirus

Sensitivity and accuracy in COVID-19 testing

Posted on Wed, Aug 19, 2020 @ 07:56 AM

Following up with the panelists from our recent COVID-19 webinar, Part 2 of 3 In the face of a rapidly evolving ...

Topics: Molecular Diagnostics, Genomics, Coronavirus

Scaling up COVID-19 viral testing

Posted on Wed, Aug 12, 2020 @ 07:47 AM

Following up with the panelists from our recent COVID-19 webinar, Part 1 of 3 The COVID-19 pandemic has presented ...

Topics: Molecular Diagnostics, Genomics, Coronavirus

Enabling a rapid response to COVID-19 by Honeywell and LGC, Biosearch Technologies

Posted on Wed, Jul 29, 2020 @ 12:40 PM

As countries worldwide begin to ease lockdown restrictions during the pandemic and prepare to return to “normal” ...

Topics: Molecular Diagnostics, Genomics, qPCR, Coronavirus

Robust supply chains and open testing systems: How our AgBio roots meet the FDA's EUA process to enable solutions to the COVID-19 pandemic

Posted on Tue, May 19, 2020 @ 08:18 AM

It may seem strange that a company known for transforming the global seed breeding industry is uniquely positioned to ...

Topics: Molecular Diagnostics, Genomics, qPCR, Coronavirus

Behind the scenes: How our oligo synthesis team contributes to the reliability of your assays

Posted on Thu, Apr 30, 2020 @ 02:13 PM

We’re not rejecting you, just your oligo PCR is arguably one of the most enabling technologies of modern molecular ...

Topics: Molecular Diagnostics, Genomics, Coronavirus, Oligo synthesis

When you don’t need an EUA for SARS-CoV-2 testing

Posted on Fri, Apr 10, 2020 @ 03:00 PM

On March 25, 2020, the US Food and Drug Administration (FDA) held the first of a series of virtual town halls they will ...

Topics: Molecular Diagnostics, Coronavirus

Addressing COVID-19 together: LGC, Biosearch Technologies and Shanghai Liferiver Biotechnology Co., Ltd.

Posted on Tue, Mar 31, 2020 @ 10:13 AM

In the nearly three months since the first confirmed case of COVID-19, the outbreak has become a global crisis, with ...

Topics: Molecular Diagnostics, Custom Oligos, Genomics, Coronavirus

What diagnostic test makers and CLIA labs in the US need to know about Emergency Use Authorization (EUA)

Posted on Tue, Mar 24, 2020 @ 11:58 AM

*Since the original publication of this blog, LGC, Biosearch Technologies is now the only acceptable commercial ...

Topics: Molecular Diagnostics, Genomics, Coronavirus

Coronavirus outbreak: Collaboration to meet the challenge

Posted on Mon, Mar 16, 2020 @ 12:30 PM

Coronavirus, or COVID-19, is an infectious virus that is spreading rapidly around the world and the World Health ...

Topics: Molecular Diagnostics, Genomics, Coronavirus

Welcome to the BiosearchTech Blog

When you don’t need an EUA for SARS-CoV-2 testing